Senior insider sale
BIOCRYST PHARMACEUTICALS INC — senior position signals high conviction
$2.65M
306K shares
What this filing means
STONEHOUSE JON P plans to sell 306K shares of BIOCRYST PHARMACEUTICALS INC valued at approximately $2.65M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/2/2026ACC: 0001959173-26-001679
Director
Since Feb 2026
306K
Shares to sell
$2.65M
Approx. market value
306K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Option Granted - 05/23/2016
Cash
3/2/2026
306KTotal acquired306K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/2/2026 | Option Granted - 05/23/2016 Cash | 306K | — |
| Total | 306K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
306K
Market value
$2.65M
3/2/2026
Total
Units
306K
Value
$2.65M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/2/2026 | 306K | $2.65M | NASDAQ | Planned |
| Total | 306K | $2.65M | ||